World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-9k9hhv
Date of registration: 11/07/2011
Primary sponsor: Universidade Nove de Julho - UNINOVE - Brazil
Public title: Study of sleep, respiratory control during sleep and quality of life in morbidly obese subjects undergoing bariatric surgery.
Scientific title: Sleep study, respiratory mechanics, chemosensitive response and quality of life in morbidly obese patients undergoing bariatric surgery: A prospective, randomized, controlled
Date of first enrolment:
Target sample size: 17
Recruitment status: recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-9k9hhv/
Study type: 
Study design:  Prospective, randomized, controlled trial, two arms, blind paralel study.  
Countries of recruitment
Brazil
Contacts
Name: Luis Vicente  Oliveira
Address:  Avenida Francisco Matarazzo, 612 - Agua Branca 05001100 Sao Paulo Brazil
Telephone: +551136659890
Email: oliveira.lvf@uninove.br
Affiliation:  Universidade Nove de Julho - UNINOVE
Name: Luis Vicente  Oliveira
Address:  Avenida Francisco Matarazzo, 612 - Agua Branca 05001100 São Paulo Brazil
Telephone: +551136659890
Email: oliveira.lvf@uninove.br
Affiliation:  Universidade Nove de Julho - UNINOVE
Key inclusion & exclusion criteria
Inclusion criteria: Grade III morbid obesity (BMI between 40 and 55 kg/m²) or between 35 and 39 kg/m² with comorbidities;
Both gender patients aged 18 to 65 years;
Documented history of conventional weight loss attempts having proven unsuccessful over time;
Agreement to participate in the study through a signed term of informed consent.

Exclusion criteria: Any medical condition rendering surgery too risk;
Clinically significant or unstable mental health concerns;
Pregnancy, lactation or planned pregnancy within two years of potential surgical treatment;
Smokers (at least 8 weeks prior to surgery), abusive alcohol use and/or drugs use.


Age minimum: 18Y
Age maximum: 65Y
Gender: -
Health Condition(s) or Problem(s) studied
We will study subjects with morbid obesity, considered nutritional and metabolic disease, undergone bariatric surgery, for investigation of sleep disorders, especially obstructive sleep apnea.
E02.065.062
C08.618.085.852.850
C18.654.726.500
C10.886
Intervention(s)
Subjects morbid obese undergone bariatric surgery will be asked to participe in the study. All the subjects' evaluations will occur prior to the surgical intervention and 30, 90 and 360 days following the procedure. All subjects in both groups will be submitted to the following evaluation protocol. General clinical measurements will be performed include body weight (kg), height (m), calculation of body mass index (BMI) using the formula weight/height2, circumferences (cm) of the neck, waist, and hip, heart and respiratory rates, blood pressure values, Mallampati index, tonsil index , the administration of specific questionnaires for sleep apnoea and excessive daytime sleepiness and a quality of life questionnaire and standart overnight polysomnography.
The intervention group will be composed of subjects who underwent bariatric surgery and control groups by the subjects that will not be subjected to surgery due to the extensive waiting list associated with small service demand, although they are suited to the surgical procedure.
Primary Outcome(s)
Apnea/hypopnea index by standard overnight polysomnography.
Sleep study will be performed with an standard overnight polysomnography monitoring system recording EEG, EMG and EOG, thoracic and abdominal movements by strain gauges, oro-nasal airflow by thermistor, snoring, body position, heart rate by cardiotachography, and pulse oximetry. An apnea was defined as the absence of airflow for more than 10 seconds and classified as central in the absence of thoraco-abdominal movements. Hypopnea was defined as a 50% decrease of airflow and thoraco-abdominal movements with a consensual oxyhaemoglobin desaturation, and classified as central hypopnea in the absence of paradoxical movements of thorax and abdomen.
Slope of ventilatory response to carbon dioxide performed by spirometry. The rebreathing test was performed according to Read technique. Patients breathed through a mouthpiece and, after a steady state was achieved, basal ventilation was recorded for three minutes. Then patients started to breath connected to a 15 L latex balloon filled with a 7% CO2 and 93% O2 mixture for five minutes or until an end-tidal CO2 pressure PetCO2 of 70 mm Hg was reached or until exhaustion. Data were acquired by a metabolic cart (Vmax 29c, Sensor Medics, USA) and the slope of ventilatory response to carbon dioxide was obtained from the linear regression between ventilation and PetCO2. Data were adjusted by a 0.9 correction factor to correct flow readings for hyperoxic gas mixture.
Secondary Outcome(s)
Evaluation of the risk to obstructive sleep apnea through Berlin Questionn
Evaluation of diurnal sleepiness intensity by the Epworth Sleepiness Scale.
Evaluation of quality of life, weight loss percentage and changes in medical conditions through the Bariatric Analysis and Reporting Outcome System (Baros).
Maximal inspiratory pressure and maximal expiratory pressure evaluated by digital manovacuometer.
Sleep physiological variables assessed by the standart overnight polysomnography.
The measurements of waist and neck circumference at physical exam.
Thorax and abdomen cirtometry at physical exam.
Weight loss evaluated by Body mass index.
Secondary ID(s)
220506/2009
481169/2008-3
Source(s) of Monetary Support
Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq) - Brazil
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history